stockrowICU Medical, Inc.
ICUI Healthcare Medical Instruments & Supplies
ICU Medical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.2 billion, down 6.33% from fiscal 2024.
- Revenue
- +4.37%
- EPS
- +864.3%
- Free cash flow
- +292.2%
- Total debt
- −12.3%
Quarter to September 2026, against a year earlier
Follow ICUI
Alert me
ICU Medical, Inc. (ICUI) Revenue growth
ICU Medical, Inc.'s revenue growth over the twelve months to 30 September 2026 was −5.92%, up 0.4 percentage points from fiscal 2025 (−6.33%). Over the past ten years it has ranged from −9.56% (fiscal 2019) to 240.7% (fiscal 2017); the current reading is higher than 18% of that period. That is below the Medical Instruments & Supplies industry median of 8.97% and below the Healthcare sector median of 7.80%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | −6.33% | (11.77) |
| FY2024 | 5.44% | 6.36 |
| FY2023 | −0.92% | (74.13) |
| FY2022 | 73.2% | 69.65 |
| FY2021 | 3.56% | 3.18 |
| FY2020 | 0.38% | 9.94 |
| FY2019 | −9.56% | (17.87) |
| FY2018 | 8.31% | (232.41) |
| FY2017 | 240.7% | 229.68 |
| FY2016 | 11.0% | 0.56 |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Sep 2026 | 4.37% | 3.86 |
| Jun 2026 | 0.51% | 12.83 |
| Mar 2026 | −12.3% | 1.83 |
| Dec 2025 | −14.2% | (5.30) |
| 43 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| PLSE Pulse Biosciences, Inc compare | 90.1% |
| TFX Teleflex Incorporated compare | 30.7% |
| ATRC AtriCure, Inc. compare | 13.8% |
| STVN Stevanato Group S.p.A. compare | 11.6% |
| WRBY Warby Parker Inc. compare | 9.89% |
| NVST Envista Holdings Corporation compare | 9.78% |
| MMSI Merit Medical Systems, Inc. compare | 9.06% |
| ICUI ICU Medical, Inc. | −5.92% |
| MMED MiniMed Group, Inc. compare | — |
| Medical Instruments & Supplies industry median | 8.97% |
| Healthcare sector median | 7.80% |
| Market median | 7.58% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on ICUI
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement